Target intelligence / Profile preview

Multiple predicted and phenotypic targets – not individually validated for this decoction

Molecular classification
Other
01

Overview

Multiple predicted and phenotypic targets – not individually validated for this decoction is a classification used in pharmacological databases, such as ChEMBL, to describe the collective biological activity of complex mixtures like herbal decoctions (ChEMBL, 2024). Unlike purified drug compounds that interact with a specific protein, these mixtures often exert therapeutic effects through polypharmacology, where numerous chemical constituents hit multiple receptors and enzymes simultaneously (PubMed: 28630309). The term "phenotypic" refers to the fact that the observed effects are documented through changes in cellular or physiological traits rather than through validated binding to a single molecular target. Because these interactions are often predicted via computational models or network pharmacology rather than confirmed through individual biochemical assays, they remain individually unvalidated (PubMed: 30103440). This category highlights the inherent difficulty in applying a reductionist pharmacological framework to traditional medicines that rely on synergistic multi-target interactions. Consequently, while such decoctions may show efficacy in treating complex conditions like inflammation or metabolic syndrome, their precise molecular mechanisms are not yet fully characterized. As a result, this entry functions as a necessary placeholder for data that does not fit the standard one-drug-one-target paradigm.

Other names
Predicted targets of herbal decoctionsPhenotypic targets of complex mixturesUnvalidated polypharmacological targets
02

Mechanism of action

Polypharmacology involving the simultaneous modulation of multiple uncharacterized molecular pathways and receptors (PubMed: 28630309).

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Lack of molecular specificityPotential for unpredictable drug-drug interactionsBatch-to-batch chemical variabilityUnknown off-target toxicities
06

Interacting drugs

Herbal decoctions

2 more in the full profile.

Beyond the preview

Go deeper on Multiple predicted and phenotypic targets – not individually validated for this decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple predicted and phenotypic targets – not individually validated for this decoction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call